drugset / Trial / NCT05990933

Role of Adrenaline in in the Inflammatory Response in Diabetes

NCT05990933

Completed 30 enrolled Cees Tack
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The primary aim of the present study is to study the effect of adrenaline administration on inflammatory parameters (e.g. leukocyte phenotype, cytokines, inflammatory proteins). Secondary objectives consist of the effect of adrenaline on atherogenic parameters. * All participants will receive intravenous infusion of adrenaline for an hour * We will draw blood at 7 time points, not including screening * Participants will be asked to return for a total of 4 times Researchers will compare 2 groups, healthy individuals versus people with diabetes type 1 to see if the inflammatory reaction to adrenaline differs between these two groups.

Timeline

Start
2023-12-03
Primary completion
2024-09-03
Completion
2024-09-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 0.04 ug/kg Intravenous